Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,572.70
(
-0.78%
)
US TECH 100
23,581.60
(
-0.90%
)
Dow Jones
45,780.72
(
-0.96%
)
Brent Oil
108.04
(
1.37%
)
Bitcoin
68,799.98
(
-3.43%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 64
Posts 11870
Boards Moderated 0
Alias Born 07/16/2006

jbog

Re: DewDiligence post# 198918

Saturday, 01/09/2016 5:27:37 PM

Saturday, January 09, 2016 5:27:37 PM

Post# of 257259
I haven't followed it recently but the partneship between Biocon of India and Mylan should have many Biosimilars in phase 3 at this time.

Adalimumab (Humira), Pegfilgrastim (Neulasta), Trastuzumab (Herceptin) and Bevacizumab (Avastin) were all in progress at one time. I haven't heard any change. Their were numerous insulin's involved in their deal also.

http://www.biosimilarnews.com/two-biocon-mylan-biosimilar-drugs-enter-global-clinical-trials
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now